Aripiprazole generichealth

Country: New Zealand

Lingwa: Ingliż

Sors: Medsafe (Medicines Safety Authority)

Ingredjent attiv:

Aripiprazole 15mg

Disponibbli minn:

CARSL Consulting

INN (Isem Internazzjonali):

Aripiprazole 15 mg

Dożaġġ:

15 mg

Għamla farmaċewtika:

Tablet

Kompożizzjoni:

Active: Aripiprazole 15mg Excipient: Hyprolose Lactose monohydrate Magnesium stearate Maize starch Microcrystalline cellulose

Tip ta 'preskrizzjoni:

Prescription

Manifatturat minn:

Ind-Swift Laboratories Limited

Indikazzjonijiet terapewtiċi:

Aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy. Aripiprazole monotherapy is indicated for acute and maintenance treatment of manic and mixed episodes with Bipolar I Disorder with or without psychotic features. Aripiprazole is indicated as an adjunctive therapy to either lithium or valporate for the acute treatment of manic and mixed episodes associated with Bipolar I Disorder with or without psychotic features.

Sommarju tal-prodott:

Package - Contents - Shelf Life: Blister pack, Al/Al - 30 tablets - 36 months from date of manufacture stored at or below 30°C

Data ta 'l-awtorizzazzjoni:

2013-05-10